This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 834,570 Years Active: 2025
Title: Martin Biel - Innovator in Gene Therapy
Introduction
Martin Biel is a prominent inventor based in Munich, Germany. He has made significant contributions to the field of gene therapy, particularly in the treatment of retinal diseases. His innovative work focuses on developing solutions for conditions that affect vision.
Latest Patents
Martin Biel holds a patent for a groundbreaking invention titled "Gene therapy for the treatment of CNGB1-linked retinitis pigmentosa." This invention involves a polynucleotide that comprises a promoter with a human photoreceptor-specific promoter element, a core promoter, and at least one transgene. Additionally, the patent includes a plasmid, a viral vector, and a pharmaceutical composition that utilizes the polynucleotide. These components are designed for use as a medicament, specifically targeting diseases of the retina.
Career Highlights
Throughout his career, Martin Biel has focused on advancing medical science through innovative research and development. His work has led to the creation of effective therapeutic strategies that address critical health issues related to vision.
Collaborations
Martin Biel collaborates with Stylianos Michalakis, contributing to the advancement of gene therapy research and development.
Conclusion
Martin Biel's contributions to gene therapy exemplify the impact of innovation in medical science. His work continues to pave the way for new treatments that can improve the quality of life for individuals affected by retinal diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile